| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lipocine Inc. | Principal Accounting Officer | Stock Option (Right to Buy) | 40,146 | $168,613 | $4.2 | 18 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LPCN | Lipocine Inc. | 18 Dec 2025 | 1 | $87,301 | 4 | Principal Accounting Officer | 19 Dec 2025, 17:07 |
| LPCN | Lipocine Inc. | 23 Dec 2024 | 1 | $28,526 | 4 | Principal Accounting Officer | 30 Dec 2024, 20:03 |
| LPCN | Lipocine Inc. | 08 Mar 2024 | 1 | $0 | 4 | Principal Accounting Officer | 12 Mar 2024, 17:51 |
| LPCN | Lipocine Inc. | 22 Dec 2022 | 1 | $37,658 | 4 | Principal Accounting Officer | 22 Dec 2022, 18:18 |
| LPCN | Lipocine Inc. | 17 May 2022 | 1 | $10,750 | 4 | Principal Accounting Officer | 17 May 2022, 16:58 |
| LPCN | Lipocine Inc. | 19 Jan 2022 | 0 | $0 | 3 | Principal Accounting Officer | 27 Jan 2022, 08:15 |